Editorial Board — Medscape Ophthalmology

Board Members

  • Ronald C. Gentile, MD
    • The New York Eye & Ear Infirmary of Mount Sinai
      Gentile Retina
      New York, New York
  • Ivan Goldberg, MBBS
    • University of Sydney
      Sydney Eye Hospital
      Sydney, Australia
  • L. Jay Katz, MD
    • Sidney Kimmel Medical College
      Thomas Jefferson University
      Wills Eye Institute
      Philadelphia, Pennsylvania
 

Board Member Details

David M. Brown, MD
David M. Brown, MD

Associate Professor, Department of Ophthalmology, The Methodist Hospital, Weill Cornell College of Medicine; Director of Clinical Research, Retina Consultants of Houston, Houston, Texas

David M. Brown, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Genentech/Roche; Regeneron Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation; Avedrum Biotechnologies, Inc.; Santeen; Samsung; Senju; Ohr Pharmaceutical, Inc.; ChengduKanghong Biotechnology; REGENXBIO Inc.; Clearside Biomedical Inc.; Heidelberg; Optos; Carl Zeiss Meditec; Stealth Biotherapeutics; Apellis
Received research grant from: Genentech/Roche; Regeneron Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation; Avedrum Biotechnologies, Inc.; Santeen; Samsung; Senju; Heidelberg; Ohr Pharmaceutical, Inc.; ThromboGenics, Inc.; REGENXBIO Inc.; Clearside Biomedical Inc.
Received income in an amount equal to or greater than $250 from: Genentech/Roche; Regeneron Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation; Avedrum Biotechnologies, Inc.; Santeen; Samsung; Senju; Clearside Biomedical Inc.; Heidelberg; Optos; Carl Zeiss Meditec; Ohr Pharmaceutical, Inc.; REGENEXBIO Inc.; ChengduKanghong Biotechnology; Apellis; Stealth Biotherapeutics

David K. Coats, MD
David K. Coats, MD

Professor of Ophthalmology and Pediatrics/Ophthalmology, Baylor College of Medicine; Chief, Department of Ophthalmology/Ophthalmology Clinic, Texas Children's Hospital, Houston, Texas

David K. Coats, MD, has disclosed no relevant financial relationships.

H. Burkhard Dick, MD, PhD
H. Burkhard Dick, MD, PhD

H. Burkhard Dick, MD, PhD, Professor and Chairman, Center for Vision Science, Ruhr University Eye Hospital, Bochum, Germany

H. Burkhard Dick, MD, PhD, has disclosed the following relevant financial relationships:
Served as a board member (unpaid) for: Atia Medical/Shifamed, LLC; Avellino Lab USA, Inc.; Carl Zeiss Meditec; InfiniteVision Optics SAS; Medicem Group B.V.; Optical Express Inc.; Pharm-Allergan GmbH; Vivior AG; WebMD, LLC
Serve(d) as a consultant for: Avedro Inc.; Carl Zeiss Meditec; Johnson & Johnson Vision; Medicem Group B.V.; Optical Express Inc.; Polytech Domilens GmbH; RxSight, Inc.
Serve(d) as a consultant for (unpaid): AcuFocus, Inc.; Atia Medical/Shifamed, LLC; Avellino Lab USA, Inc.; Excel Lens Inc.
Received grants paid to the institution/grants pending from: AbbVie GmbH & Co. KG; AcuFocus, Inc.; Allergan GmbH; Avedro Inc.; Bayer Healthcare AG; Carl Zeiss Meditec; F. Hoffmann-La Roche Ltd; Implandata Ophthalmic Products GmbH; Johnson & Johnson Vision; Medicem Group B.V.; Novartis Pharmaceuticals Corporation GmbH; Ophtec BV; OSD Medical GmbH; Powervision, Inc.; ROWIAK GmbH; URSAPHARM Arzneimittel GmbH
Received payment for lectures including service on speakers bureau for: Johnson & Johnson Vision; Bausch + Lomb Inc.
Holds patents from: Johnson & Johnson
Received royalties from: Morcher GmbH; Oculus Inc.

Ronald C. Gentile, MD

Clinical Professor of Ophthalmology, The New York Eye & Ear Infirmary of Mount Sinai; President and Director, Gentile Retina, New York, New York

Ronald C. Gentile, MD, has disclosed no relevant financial relationships.

Ivan Goldberg, MBBS
Ivan Goldberg, MBBS

Clinical Associate Professor, Discipline of Ophthalmology, University of Sydney; Head, Glaucoma Unit, Sydney Eye Hospital, Sydney, Australia

Ivan Goldberg, MBBS, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Allergan, Inc.; Mundipharma; Novartis Pharmaceuticals Corporation; Pfizer Inc.
Serve(d) as a speaker or a member of a speakers bureau for: Allergan, Inc.; Mundipharma; Novartis Pharmaceuticals Corporation; Pfizer Inc.
Received research grant from: Novartis Pharmaceuticals Corporation
Received income in an amount equal to or greater than $250 from: Allergan, Inc.; Mundipharma; Novartis Pharmaceuticals Corporation; Pfizer Inc.

L. Jay Katz, MD
L. Jay Katz, MD

Director, Glaucoma Service, Wills Eye Hospital; Professor of Ophthalmology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania

L. Jay Katz, MD, has disclosed the following relevant financial relationships:
Serve(d) as a consultant/on the advisory board for: Allergan, Inc.; Alcon Laboratories, Inc.; Glaukos; Aerie Pharmaceuticals, Inc.; Diospys; Mati Therapeutics; Aerpio Therapeutics
Serve(d) as a speaker or member of a speakers bureau for: Allergan, Inc.; Alcon Laboratories, Inc.; Glaukos; Bausch & Lomb Inc.; Aerie Pharmaceuticals, Inc.
Received grant/research support from: Allergan, Inc.; Alcon Laboratires, Inc.; Diopsys; Heidelberg Engineering; Carl Zeiss Meditec
Has stock in: Glaukos; Mati Therapeutics; Aerie Pharmaceuticals, Inc.
Chief Medical Officer: Glaukos